Lonza Q1 2025 Qualitative Update: Strong Performance Across All Businesses in Line with Expectations for Full-Year 2025
Strong CDMO1 performance in Q1 2025, in line with expectations for FY 2025 Robust commercial demand in CDMO business with high utilization in early-stage business, Bioscience...